ESTRO 2022 - Abstract Book

SUNDAY 8 MAY 2022

Teaching Lecture MR-guided radiotherapy: How to acquire and interpret imaging data for online adaption............................... (abs. 337) Mitochondria in tumour and normal tissue radiobiology...................................................................................... (abs. 338) Breast cancer-related lymphoedema....................................................................................................................... (abs. 339) Fractionation and biology in bladder cancer........................................................................................................... (abs. 340) Artificial intelligence and brachytherapy: Current reality and perspectives. ..............................................(abs. 341 - 342) Robust treatment planning in particle therapy: Clinical implementation and potential pitfalls........................ (abs. 343) Essentials for risk management of a radiation oncology department.................................................................. (abs. 344) Less is more: The increasing use of hypofractionation in routine clinical practice and its impact on patient care. ........................................................................................................................(abs. 345 - 346) Symposium Radiation-induced cardiac and vascular toxicity............................................................................................(abs. 347 - 350) Beyond the nucleus: The role of mitochondria in radiation response. .......................................................(abs. 351 - 354) Radiotherapy in head and neck advanced disease in surgery with reconstruction area. .........................(abs. 355 - 358) 2020 - Losing ground for radiotherapy?..........................................................................................................(abs. 359 - 362) The use of imaging in prostate brachytherapy. .............................................................................................(abs. 363 - 365) Image guidance in particle therapy: Status and outlook...............................................................................(abs. 366 - 369) Pitch Session Every radiotherapy physicist should know about AI/ML... but how much?.................................................(abs. 370 - 375) Symposium Personalised radiotherapy: Improving standards of care with personalised treatments.........................(abs. 376 - 378) Mini-Oral 09: Personalised radiation therapy. ................................................................................................................(abs. 379 - 386) 10: Lung..............................................................................................................................................................(abs. 387 - 394) Poster Discussion 09: Inter-fraction motion & adaptive radiotherapy........................................................................................(abs. 395 - 406) 10: Urology 1......................................................................................................................................................(abs. 407 - 418) Proffered Papers MR-guided radiotherapy...................................................................................................................................(abs. 419 - 424) Tumour radiobiology. .......................................................................................................................................(abs. 425 - 430) Head & neck.......................................................................................................................................................(abs. 431 - 436) Lung....................................................................................................................................................................(abs. 437 - 442) Gynaecology.......................................................................................................................................................(abs. 443 - 448) Optimisation & algorithms in proton & ion radiotherapy.............................................................................(abs. 449 - 454) Radiomics & modelling. ....................................................................................................................................(abs. 455 - 460) AI & advanced practice. ....................................................................................................................................(abs. 461 - 466) Mini-Oral 11: Intra-fraction motion management. .........................................................................................................(abs. 467 - 474) 12: Head and neck.............................................................................................................................................(abs. 475 - 482) Poster Discussion 11: Radiobiology................................................................................................................................................(abs. 483 - 490) 12: GI...................................................................................................................................................................(abs. 491 - 502) Proffered Papers Highlights of Proffered Papers - Best Papers. ................................................................................................(abs. 503 - 508) Symposium Management of radio-recurrent prostate cancer..........................................................................................(abs. 509 - 512) The hypoxic tumour microenvironment.........................................................................................................(abs. 513 - 516) Joint Symposium ESTRO-EORTC: Oligometastatic Disease. ........................................................................................................(abs. 517 - 520) ESTRO-IASLC: Advances in radiotherapy for lung cancer..............................................................................(abs. 521 - 524) Symposium Ocular plaque brachytherapy. .........................................................................................................................(abs. 525 - 527)